Societe Generale S.A.:企業の戦略・SWOT・財務情報

◆英語タイトル:Societe Generale S.A. - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA904C3928
◆発行会社(調査会社):MarketLine
◆発行日:2018年8月
◆ページ数:61
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フランス
◆産業分野:サービス
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Societe Generale S.A. – Strategy, SWOT and Corporate Finance Report
Summary

Societe Generale S.A. – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Societe Generale S.A. (Societe Generale or ‘the group’) is one of Europe’s leading financial services groups. The group is engaged in the provision of a range of financial services, including international retail banking, corporate and investment banking, asset management, and securities services. Societe Generale is also a major player in the businesses of specialized financial services and insurance and private banking, and global investment management and services. The group operates in Europe, Africa and the Middle-East, Asia and Oceania, and the Americas. It is headquartered in Paris, France.

Scope

- Detailed information on Societe Generale S.A. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Societe Generale S.A. in the form of a SWOT analysis
- An in-depth view of the business model of Societe Generale S.A. including a breakdown and examination of key business segments
- Intelligence on Societe Generale S.A.’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Societe Generale S.A., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Societe Generale S.A. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Societe Generale S.A. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Societe Generale S.A.’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 5
Societe Generale S.A.: Company Overview 9
Societe Generale S.A.: Overview and Key Facts 9
Societe Generale S.A.: Overview 9
Societe Generale S.A.: Key Facts 9
Societe Generale S.A.: Key Employees 10
Societe Generale S.A.: Key Employee Biographies 16
Societe Generale S.A.: Major Products and Services 25
Societe Generale S.A.: Company History 27
Societe Generale S.A.: Management Statement 33
Societe Generale S.A.: Locations and Subsidiaries 35
Societe Generale S.A.: Key Competitors 37
Societe Generale S.A.: Company Analysis 38
Societe Generale S.A.: Business Description 38
Societe Generale S.A.: SWOT Analysis 40
Societe Generale S.A.: SWOT Overview 40
Societe Generale S.A.: Strengths 40
Societe Generale S.A.: Weaknesses 41
Societe Generale S.A.: Opportunities 41
Societe Generale S.A.: Threats 42
Societe Generale S.A.: Corporate Financial Deals Activity 43
Societe Generale S.A.: Financial Deals Overview 43
Societe Generale S.A.: Targets and Partners 45
Societe Generale S.A.: Top Deals 2014 – 2018YTD* 46
Societe Generale S.A.: Advisors 47
Societe Generale S.A.: Top Legal Advisors 47
Societe Generale S.A.: Top Financial Advisors 47
Societe Generale S.A.: Mergers and Acquisitions 48
Societe Generale S.A.: Corporate Venturing 49
Societe Generale S.A.: Capital Raising 50
Societe Generale S.A.: Divestments 51
Societe Generale S.A.: Recent Developments 52
Societe Generale S.A.: News and Events Summary 52
Societe Generale S.A.: Business Expansion 54
Societe Generale S.A.: Contracts 55
Societe Generale S.A.: Corporate Governance 55
Societe Generale S.A.: Financial Deals 56
Societe Generale S.A.: Financial Performance 57
Societe Generale S.A.: Regulatory and Legal Events 57
Societe Generale S.A.: Strategy and Operations 58
Appendix 59
Contact Us 59
Methodology 59
About MarketLine 60

List of Tables
Table 1: Societe Generale S.A.: Key Facts
Table 2: Societe Generale S.A.: Key Employees
Table 3: Societe Generale S.A.: Locations and Subsidiaries
Table 4: Societe Generale S.A.: Key Competitors
Table 5: Societe Generale S.A.: Deal Activity by Deal Type - Volume (TTM*)
Table 6: Societe Generale S.A.: M&A Activity by Geography (TTM*)
Table 7: Societe Generale S.A.: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 8: Societe Generale S.A.: M&A Average Deal Size - Value (US$m)
Table 9: Societe Generale S.A.: Targets and Partners
Table 10: Societe Generale S.A.: Top Deals 2014 - 2018YTD*
Table 11: Societe Generale S.A.: Legal Advisor Ranking by Value (US$m)
Table 12: Societe Generale S.A.: Financial Advisor Ranking by Value (US$m)
Table 13: Societe Generale S.A.: M&A Volume and Value Trend (2014 - YTD*2018)
Table 14: Societe Generale S.A.: M&A Activity by Geography (2014 - YTD*2018)
Table 15: Societe Generale S.A.: Corporate Venturing Volume and Value Trend (2014 - YTD*2018)
Table 16: Societe Generale S.A.: Corporate Venturing by Geography (2014 - YTD*2018)
Table 17: Societe Generale S.A.: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Table 18: Societe Generale S.A.: Capital Raising by Deal Type (2014 - YTD*2018)
Table 19: Societe Generale S.A.: Divestments Volume and Value Trend (2014 - YTD*2018)
Table 20: Societe Generale S.A.: Divestments by Geography (2014 - YTD*2018)
Table 21: Societe Generale S.A.: News and Events Summary
Table 22: Societe Generale S.A.: Business Expansion
Table 23: Societe Generale S.A.: Contracts
Table 24: Societe Generale S.A.: Corporate Governance
Table 25: Societe Generale S.A.: Financial Deals
Table 26: Societe Generale S.A.: Financial Performance
Table 27: Societe Generale S.A.: Regulatory and Legal Events
Table 28: Societe Generale S.A.: Strategy and Operations

List of Figures
Figure 1: Societe Generale S.A.: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Societe Generale S.A.: M&A Activity by Geography (TTM*)
Figure 3: Societe Generale S.A.: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 4: Societe Generale S.A.: M&A Average Deal Size - Value (US$m)
Figure 5: Societe Generale S.A.: M&A Volume and Value Trend (2014 - YTD*2018)
Figure 6: Societe Generale S.A.: M&A Activity by Geography (2014 - YTD*2018)
Figure 7: Societe Generale S.A.: Corporate Venturing Volume and Value Trend (2014 - YTD*2018)
Figure 8: Societe Generale S.A.: Corporate Venturing by Geography (2014 - YTD*2018)
Figure 9: Societe Generale S.A.: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Figure 10: Societe Generale S.A.: Capital Raising by Deal Type (2014 - YTD*2018)
Figure 11: Societe Generale S.A.: Divestments Volume and Value Trend (2014 - YTD*2018)
Figure 12: Societe Generale S.A.: Divestments by Geography (2014 - YTD*2018)

★海外企業調査レポート[Societe Generale S.A.:企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • SciClone Pharmaceuticals Inc (SCLN)-製薬・医療分野:企業M&A・提携分析
    Summary SciClone Pharmaceuticals Inc (SciClone) develops and commercializes products for the treatment of cancer, cardiovascular disorders and infectious diseases. The company’s lead product, Zadaxin (thymalfasin), an immunostimulatory agent approved for the treatment of hepatitis B virus (HBV), hep …
  • Tata Teleservices (Maharashtra) Limited (TTML):企業の財務・戦略的SWOT分析
    Tata Teleservices (Maharashtra) Limited (TTML) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key str …
  • Alethia Biotherapeutics Inc-製薬・医療分野:企業M&A・提携分析
    Summary Alethia Biotherapeutics Inc (Alethia Biotherapeutics) is a biotechnology company that discovers and develops therapeutic products. The company’s products comprise AB-25E9 bone antiresorptive, AB-3A4 invasive carcinomas treatment products, and AB-16B5 EMT inhibitors. It also offers therapeuti …
  • Kuwait Food Company (Americana) KSCP:企業の戦略的SWOT分析
    Kuwait Food Company (Americana) KSCP - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and majo …
  • Integer Holdings Corp (GB):企業の財務・戦略的SWOT分析
    Summary Integer Holdings Corp (Integrated Holdings), formerly Greatbatch Inc is a medical device outsource manufacturer that designs and develops medical devices and power solutions for the medical and non-medical markets. The company offers products such as arthroscopic devices and components, lapa …
  • Intuitive Surgical Inc (ISRG):企業の財務・戦略的SWOT分析
    Intuitive Surgical Inc (ISRG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Logitech International S.A.:企業の戦略・SWOT・財務分析
    Logitech International S.A. - Strategy, SWOT and Corporate Finance Report Summary Logitech International S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • The PNC Financial Services Group Inc:企業のM&A・事業提携・投資動向
    The PNC Financial Services Group Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's The PNC Financial Services Group Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports …
  • Marel hf:企業の戦略・SWOT・財務分析
    Marel hf - Strategy, SWOT and Corporate Finance Report Summary Marel hf - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Aksigorta A.S. (AKGRT):企業の財務・戦略的SWOT分析
    Aksigorta A.S. (AKGRT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Shanghai Pharmaceutical Co Ltd (601607):医療機器:M&Aディール及び事業提携情報
    Summary Shanghai Pharmaceutical Co Ltd (Shanghai Pharma) is a manufacturer, retailer, wholesaler and distributor of healthcare products. The company carries out the research and development, manufacture and sale of pharmaceutical products for treating HER2 positive advanced breast cancer, systemic a …
  • Sterigenics International LLC:医療機器:M&Aディール及び事業提携情報
    Summary Sterigenics International LLC (SteriGenics), formerly Radiation Sterilizers Inc, a subsidiary of Gtcr Llc, is a medical device company that offers sterilization technologies such as gamma irradiation, electron beam and ethylene oxide. The company was formerly known as Radiation Sterilizers, …
  • NCC AB:戦略・SWOT・企業財務分析
    NCC AB - Strategy, SWOT and Corporate Finance Report Summary NCC AB - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, prov …
  • Powerflute Oy:企業の戦略的SWOT分析
    Powerflute Oy - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Vectren Corp (VVC):石油・ガス:M&Aディール及び事業提携情報
    Summary Vectren Corp (Vectren) is an energy holding company, which carries out the distribution and transmission of natural gas and electricity. Under its wholly owned subsidiary, Vectren Utility Holdings, Inc., the company operates three utilities; Vectren Energy Delivery of Indiana - North (Vectre …
  • Golden Meditech Holdings Ltd (801):医療機器:M&Aディール及び事業提携情報
    Summary Golden Meditech Holdings Ltd (Golden Meditech) is a medical equipment provider that provides blood stem cells storage and hospital management solutions. The company provides autologous blood recovery systems. It offers hospital management, medical insurance administration and blood bank serv …
  • Caltex Australia Ltd (CTX)-石油・ガス分野:企業M&A・提携分析
    Summary Caltex Australia Limited (Caltex) is a transport fuel supplier and convenience retailer. It is the parent company of Caltex group. The company purchases, refines, distributes and markets petroleum products. It owns and operates refinery, convenience stores, road tankers, storage terminals, s …
  • Karnataka Power Corporation Ltd:企業の戦略的SWOT分析
    Karnataka Power Corporation Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • Correvio International Sarl-製薬・医療分野:企業M&A・提携分析
    Summary Correvio International Sarl (Correvio International), formerly Iroko Cardio International Sarl, a subsidiary of Cardiome Pharma Corp, healthcare solution provider. The company develops an integrated pharmaceutical platform that offers production, distribution, regulatory, medical, health eco …
  • Volkswagen AG:戦略・SWOT・企業財務分析
    Volkswagen AG - Strategy, SWOT and Corporate Finance Report Summary Volkswagen AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆